Patents by Inventor Emma Reuschel

Emma Reuschel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INTRADERMAL MERS-CoV VACCINE
    Publication number: 20240016919
    Abstract: The present invention disclosed an intradermal vaccine that protects against Middle East Respiratory Syndrome coronavirus (MERS-CoV). In one embodiment, the vaccine is a DNA vaccine. In one embodiment, the vaccine comprises an antigen. The antigen can be a consensus antigen. The consensus antigen can be a consensus spike antigen. The present invention also discloses methods of treating or preventing MERS-CoV in a subject in need thereof by administering the vaccine intradermally to the subject.
    Type: Application
    Filed: August 24, 2021
    Publication date: January 18, 2024
    Inventors: Ami Patel, David Weiner, Kar Muthumani, Emma Reuschel
  • CANINE DISTEMPER VACCINES AND METHODS OF TREATMENT USING THE SAME
    Publication number: 20210401970
    Abstract: Disclosed herein are compositions and methods for treating and/or preventing Canine Distemper Virus (CDV) in mammals susceptible to CDV.
    Type: Application
    Filed: October 25, 2019
    Publication date: December 30, 2021
    Inventors: Sophia Reeder, Emma Reuschel, David Weiner
  • SYNTHETIC MALARIA IMMUNOGENS, COMBINATIONS THEREOF, AND THEIR USE TO PREVENT AND TREAT MALARIA INFECTIONS
    Publication number: 20190307870
    Abstract: Provided herein are sequences of Plasmodium spp. liver stage exported proteins as well as expression constructs expressing the sequences. Also provided herein are methods for generating an immune response against malaria using the expression constructs provided herein.
    Type: Application
    Filed: May 19, 2017
    Publication date: October 10, 2019
    Inventors: David Weiner, Emma Reuschel, Bernadette Ferraro, Ahmed S.I. Aly